Positions

Selected Publications

Academic Article

Year Title Altmetric
2022 Iron overload phenotypes and HFE genotypes in white hemochromatosis and iron overload screening study participants without HFE p. C282Y/p.C282YPLoS One.  17. 2022
2022 Estimates of West African Ancestry in African Americans Using Alleles of Iron-Related Genes HJV, SLC40A1, and TFR2Genetic Testing and Molecular Biomarkers.  26:96-102. 2022
2021 Factors associated with IgG levels in adults with IgG subclass deficiencyBMC Immunology.  22. 2021
2020 Characterization of adult patients with IgG subclass deficiency and subnormal IgG2PLoS One.  15. 2020
2020 Estimates of European American Ancestry in African Americans Using HFE p.C282YGenetic Testing and Molecular Biomarkers.  24:578-583. 2020
2020 HLA-A and -B Type and Haplotype Frequencies in IgG Subclass Deficiency SubgroupsArchivum Immunologiae et Therapiae Experimentalis.  68. 2020
2020 Prevalence of iron deficiency in 62,685 women of seven race/ethnicity groups: The HEIRS StudyPLoS One.  15. 2020
2018 Insulin resistance and metabolic syndrome: Clinical and laboratory associations in African Americans without diabetes in the hemochromatosis and iron overload screening studyMetabolic Syndrome and Related Disorders.  16:267-273. 2018
2017 White blood cells and subtypes in HFE p.C282Y and wild-type homozygotes in the Hemochromatosis and Iron Overload Screening StudyBlood Cells, Molecules and Diseases.  63:9-14. 2017
2017 Diabetes in HFE HemochromatosisJournal of Diabetes Research.  2017. 2017
2017 Fibromyalgia in 300 adult index patients with primary immunodeficiencyClinical and Experimental Rheumatology.  35:68-73. 2017
2016 Undiagnosed diabetes and impaired fasting glucose in HFE C282Y homozygotes and HFE wild-type controls in the HEIRS studyBMJ Open Diabetes Research and Care.  4. 2016
2016 Risk Factors for Insulin Resistance, Metabolic Syndrome, and Diabetes in 248 HFE C282Y Homozygotes Identified by Population Screening in the HEIRS StudyMetabolic Syndrome and Related Disorders.  14:94-101. 2016
2016 Selective Subnormal IgG1 in 54 Adult Index Patients with Frequent or Severe Bacterial Respiratory Tract InfectionsJournal of Immunology Research.  2016. 2016
2016 Selective subnormal IgG3 in 121 adult index patients with frequent or severe bacterial respiratory tract infectionsCellular Immunology.  299:50-57. 2016
2015 HFE gene: Structure, function, mutations, and associated iron abnormalitiesGene.  574:179-192. 2015
2015 Serum ferritin, insulin resistance, and metabolic syndrome: Clinical and laboratory associations in 769 non-hispanic whites without diabetes mellitus in the HEIRS studyMetabolic Syndrome and Related Disorders.  13:57-63. 2015
2014 Diabetes in first-degree family members: A predictor of type 2 diabetes in 159 nonscreening alabama hemochromatosis probands with HFE C282Y homozygosityDiabetes Care.  37:259-266. 2014
2013 Effects of highly conserved major histocompatibility complex (MHC) extended haplotypes on iron and low CD8+ T lymphocyte phenotypes in HFE C282Y homozygous hemochromatosis patients from three geographically distant areasPLoS One.  8. 2013
2013 Association between celiac disease and iron deficiency in caucasians, but not non-caucasiansClinical Gastroenterology and Hepatology.  11:808-814. 2013
2012 Associations between single nucleotide polymorphisms in iron-related genes and iron status in multiethnic populationsPLoS One.  7. 2012
2012 Increased Risk of Death From Iron Overload Among 422 Treated Probands With HFE Hemochromatosis and Serum Levels of Ferritin Greater Than 1000 μg/L at DiagnosisClinical Gastroenterology and Hepatology.  10:412-416. 2012
2012 Dietary iron intake and serum ferritin concentration in 213 patients homozygous for the HFEC282Y hemochromatosis mutationCanadian Journal of Gastroenterology.  26:345-349. 2012
2011 Genome-wide association study identifies genetic loci associated with iron deficiencyPLoS One.  6. 2011
2010 Longer survival associated with HLA-A 03, B 14 among 212 hemochromatosis probands with HFE C282Y homozygosity and HLA-A and -B typing and haplotypingEuropean Journal of Haematology.  85:439-447. 2010
2010 Tumor necrosis factor-alpha promoter variants and iron phenotypes in 785 Hemochromatosis and Iron Overload Screening (HEIRS) Study participantsBlood Cells, Molecules and Diseases.  44:252-256. 2010
2010 Heritability of serum iron measures in the hemochromatosis and iron overload screening (HEIRS) family studyAmerican Journal of Hematology.  85:101-105. 2010
2010 Relationships of serum free thyroxine and erythrocyte measures in euthyroid HFE C282Y homozygotes and control subjects: The HEIRS StudyInternational Journal of Laboratory Hematology.  32:282-287. 2010
2009 HFE, SLC40A1, HAMP, HJV, TFR2, and FTL mutations detected by denaturing high-performance liquid chromatography after iron phenotyping and HFE C282Y and H63D genotyping in 785 HEIRS Study participantsAmerican Journal of Hematology.  84:710-714. 2009
2009 HAMP promoter mutation nc.-153C>T in 785 HEIRS Study participantsHaematologica: the hematology journal.  94:1465. 2009
2009 Hemochromatosis and Vibrio vulnificus wound infectionsJournal of Clinical Gastroenterology.  43:890-893. 2009
2009 Influence of CYP2C9 and VKORC1 on warfarin response during initiation of therapyBlood Cells, Molecules and Diseases.  43:119-128. 2009
2009 Kidney function influences warfarin responsiveness and hemorrhagic ComplicationsJournal of the American Society of Nephrology.  20:912-921. 2009
2009 Heme carrier protein 1 (HCP1) genetic variants in the Hemochromatosis and Iron Overload Screening (HEIRS) Study participantsBlood Cells, Molecules and Diseases.  42:150-154. 2009
2009 HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol the Hemochromatosis and Iron Overload Screening studyCirculation: Cardiovascular Genetics.  2:34-37. 2009
2009 A Comparison Between Whites and Blacks With Severe Multi-Organ Iron Overload Identified in 16,152 AutopsiesClinical Gastroenterology and Hepatology.  7. 2009
2009 HFE hemochromatosis and hepatic sarcoidAmerican Journal of the Medical Sciences.  337:386-390. 2009
2009 Screening for iron overload: Lessons from the HEmochromatosis and IRon Overload Screening (HEIRS) studyCanadian Journal of Gastroenterology.  23:769-772. 2009
2008 Screening for hemochromatosis and iron overload: Satisfaction with results notification and understanding of mailed results in unaffected participants of the HEIRS studyGenetic Testing and Molecular Biomarkers.  12:491-500. 2008
2008 VKORC1 polymorphims, haplotypes and haplotype groups on warfarin dose among African-Americans and European-AmericansPharmacogenomics.  9:1445-1458. 2008
2008 Accuracy of Family History of Hemochromatosis or Iron Overload: The Hemochromatosis and Iron Overload Screening StudyClinical Gastroenterology and Hepatology.  6:934-938. 2008
2008 Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and iron overload screening studyInternational Journal of Laboratory Hematology.  30:300-305. 2008
2008 Serum ferritin concentrations and body iron stores in a multicenter, multiethnic primary-care populationAmerican Journal of Hematology.  83:618-626. 2008
2008 Thyroid-stimulating hormone and free thyroxine levels in persons with HFE C282Y homozygosity, a common hemochromatosis genotype: The HEIRS studyThyroid.  18:831-838. 2008
2008 Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-AmericansPharmacogenomics.  9:511-526. 2008
2008 Characteristics of participants with self-reported hemochromatosis or iron overload at HEIRS Study initial screeningAmerican Journal of Hematology.  83:126-132. 2008
2008 Influence of CYP2C9 and VKORC1 1173C/T genotype on the risk of hemorrhagic complications in African-American and European-American patients on warfarinClinical Pharmacology and Therapeutics.  83:312-321. 2008
2008 Bivariate mixture modeling of transferrin saturation and serum ferritin concentration in Asians, African Americans, Hispanics, and whites in the Hemochromatosis and Iron Overload Screening (HEIRS) StudyTranslational Research: the journal of laboratory and clinical medicine.  151:97-109. 2008
2008 Clinical manifestations of hemochromatosis in HFE C282Y homozygotes identified by screeningCanadian Journal of Gastroenterology.  22:923-930. 2008
2007 Biological Variability of Transferrin Saturation and Unsaturated Iron-Binding CapacityAmerican Journal of Medicine.  120. 2007
2007 DMPK-associated myotonic dystrophy and CTG repeats in Alabama African AmericansClinical Genetics: an international journal of genetics and molecular medicine.  72:448-453. 2007
2007 Results communication and patient education after screening for possible hemochromatosis and iron overload: Experience from the HEIRS Study of a large ethnically and linguistically diverse groupGenetics in Medicine.  9:778-791. 2007
2007 Determinants and characteristics of mean corpuscular volume and hemoglobin concentration in white HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening StudyAmerican Journal of Hematology.  82:898-905. 2007
2007 Genetic screening for iron overload: No evidence of discrimination at 1 yearJournal of Family Practice.  56:829-834. 2007
2007 HFE C282Y homozygotes aged 25-29 years at HEIRS study initial screeningGenetic Testing and Molecular Biomarkers.  11:269-275. 2007
2007 SLC40A1 Q248H allele frequencies and Q248H-associated risk of non-HFE iron overload in persons of sub-Saharan African descentBlood Cells, Molecules and Diseases.  39:206-211. 2007
2007 African Americans at Risk for Increased Iron Stores or Liver DiseaseAmerican Journal of Medicine.  120. 2007
2007 A genome-wide linkage scan for iron phenotype quantitative trait loci: The HEIRS family studyClinical Genetics: an international journal of genetics and molecular medicine.  71:518-529. 2007
2007 Association of ferroportin Q248H polymorphism with elevated levels of serum ferritin in African Americans in the Hemochromatosis and Iron Overload Screening (HEIRS) StudyBlood Cells, Molecules and Diseases.  38:247-252. 2007
2007 Influence of CYP2C9 genotype on warfarin dose among African-Americans and European-AmericansPersonalized Medicine.  4:157-169. 2007
2007 Serum ferritin and transferrin saturation in Asians and Pacific islandersArchives of Internal Medicine.  167:722-726. 2007
2007 Psychosocial impact of genetic testing for hemochromatosis in the HEIRS Study: A comparison of participants recruited in Canada and in the United StatesGenetic Testing and Molecular Biomarkers.  11:55-64. 2007
2006 Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the hemochromatosis and iron overload screening (HEIRS) studyDiabetes Care.  29:2084-2089. 2006
2006 Impact of hemochromatosis screening in patients with indeterminate results: The hemochromatosis and iron overload screening studyGenetics in Medicine.  8:681-687. 2006
2006 Geographic and racial/ethnic differences in HFE mutation frequencies in the hemochromatosis and iron overload screening (HEIRS) studyEthnicity and Disease.  16:815-821. 2006
2006 Racial differences in the prevalence of Factor V Leiden mutation among patients on chronic warfarin therapyBlood Cells, Molecules and Diseases.  37:100-106. 2006
2006 Effect of Native American ancestry on iron-related phenotypes of Alabama hemochromatosis probands with HFE C282Y homozygosityBMC Medical Genetics.  7. 2006
2006 Predictors of belief that genetic test information about hemochromatosis should be shared with family membersGenetic Testing and Molecular Biomarkers.  10:50-59. 2006
2006 Three kinships with ALAS2 P520L (c. 1559 C → T) mutation, two in association with severe iron overload, and one with sideroblastic anemia and severe iron overloadBlood Cells, Molecules and Diseases.  36:292-297. 2006
2006 Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in Native Americans and whites in the Hemochromatosis and Iron Overload Screening StudyClinical Genetics: an international journal of genetics and molecular medicine.  69:48-57. 2006
2006 Liver Diseases in the Hemochromatosis and Iron Overload Screening StudyClinical Gastroenterology and Hepatology.  4. 2006
2006 Mixture models of serum iron measures in population screening for hemochromatosis and iron overloadTranslational Research: the journal of laboratory and clinical medicine.  148:196-206. 2006
2005 Patient acceptability of genotypic testing for hemochromatosis in primary careGenetics in Medicine.  7:557-563. 2005
2005 Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in whites and blacks in the Hemochromatosis and Iron Overload Screening StudyGenetic Testing and Molecular Biomarkers.  9:231-241. 2005
2005 Total blood lymphocyte counts in hemochromatosis probands with HFE C282Y homozygosity: Relationship to severity of iron overload and HLA-A and -B alleles and haplotypesBMC Blood Disorders.  5. 2005
2005 Comparison of the unsaturated iron-binding capacity with transferrin saturation as a screening test to detect C282Y homozygotes for hemochromatosis in 101 168 participants in the Hemochromatosis and Iron Overload Screening (HEIRS) StudyClinical Chemistry (Washington, DC): international journal of molecular diagnostics and laboratory medicine.  51:1048-1052. 2005
2005 Hemochromatosis and iron-overload screening in a racially diverse populationNew England Journal of Medicine.  352:1769-1778. 2005
2005 Genetic predictors of coronary heart disease risk factors in premenopausal African-American womenEthnicity and Disease.  15:221-232. 2005
2005 Stainable hepatic iron in 341 African American adults at coroner/medical examiner autopsyBMC Clinical Pathology.  5. 2005
2005 HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: Frequency disparity in men and women and lack of association with severity of iron overloadBlood Cells, Molecules and Diseases.  34:38-47. 2005
2004 Allele frequencies of hemojuvelin gene (HJV) 1222N and G320V missense mutations in white and African American subjects from the general Alabama populationBMC Medical Genetics.  5. 2004
2004 Countries of ancestry reported by hemochromatosis probands and control subjects in Central AlabamaEthnicity and Disease.  14:73-81. 2004
2004 Ancestry reported by white adults with cutaneous melanoma and control subjects in central AlabamaBMC Cancer.  4. 2004
2004 Genetic cancer risk assessment and counseling: Recommendations of the national society of genetic counselorsJournal of Genetic Counseling.  13:83-114. 2004
2004 HFE C282Y and H63D in adults with malignancies in a community medical oncology practiceBMC Cancer.  4. 2004
2004 Genetics and cardiovascular disease.Ethnicity and Disease.  14. 2004
2003 Vibrio vulnificus infection in a hemodialysis patient receiving intravenous iron therapyClinical Infectious Diseases.  37:63-67. 2003
2003 HLA-A and -B alleles and haplotypes in 240 index patients with common variable immunodeficiency and selective IgG subclass deficiency in central AlabamaBMC Medical Genetics.  4. 2003
2003 Hemochromatosis and iron overload screening (HEIRS) Study design for an evaluation of 100,000 primary care-based adultsAmerican Journal of the Medical Sciences.  325:53-62. 2003
2003 Common variable immunodeficiency and IgG subclass deficiency in central Alabama hemochromatosis probands homozygous for HFE C282YBlood Cells, Molecules and Diseases.  31:102-111. 2003
2003 Erratum to "The role of TNF and its receptors in Alzheimer's disease": [Neurobiology of Aging 22 (2001) 873-883]Neurobiology of Aging.  24:519-520. 2003
2003 Genotypic and phenotypic heterogeneity of African Americans with primary iron overloadBlood Cells, Molecules and Diseases.  31:310-319. 2003
2002 HLA-A and -B alleles and haplotypes in hemochromatosis probands with HFE C282Y homozygosity in central AlabamaBMC Medical Genetics.  3. 2002
2002 Survey of physician knowledge about hemochromatosisGenetics in Medicine.  4:136-141. 2002
2002 Hemochromatosis detection in a health screening program at an Alabama forest products millJournal of Occupational and Environmental Medicine.  44:745-751. 2002
2002 Juvenile hemochromatosis in the southeastern United States: A report of seven cases in two kinshipsBlood Cells, Molecules and Diseases.  29:104-115. 2002
2001 Hemochromatosis and iron therapy of Restless Legs SyndromeSleep Medicine.  2:249-251. 2001
2001 Hemochromatosis in a lithuanian with HFE C282Y homozygosity and C282Y allele frequencies in the Baltic Sea region [1]European Journal of Haematology.  67:263-264. 2001
2001 The role of TNF and its receptors in Alzheimer's diseaseNeurobiology of Aging.  22:873-883. 2001
2001 Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controlsAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics.  105:332-342. 2001
2001 A primer for predicting risk of disease in HFE-linked hemochromatosisGenetic Testing and Molecular Biomarkers.  5:311-316. 2001
2001 A rapid PCR-SSP assay for the hemochromatosis-associated Tyr250stop mutation in the TFR2 geneGenetic Testing and Molecular Biomarkers.  5:131-134. 2001
2001 HFE genotype frequencies in consecutive reference laboratory specimens: Comparisons among referral sources and association with initial diagnosisGenetic Testing and Molecular Biomarkers.  5:299-306. 2001
2001 HFE mutations in African-American women with non-insulin-dependent diabetes mellitusEthnicity and Disease.  11:578-584. 2001
2001 Inheritance of two HFE mutations in African Americans: Cases with hemochromatosis phenotypes and estimates of hemochromatosis phenotype frequencyGenetics in Medicine.  3:294-300. 2001
2001 Prevalence and risk factors of microalbuminuria in a cohort of African-American women with gestational diabetesDiabetes Care.  24:1764-1769. 2001
2001 Transferrin receptor-2 (TFR2) mutation Y250X in Alabama Caucasian and African American subjects with and without primary iron overloadBlood Cells, Molecules and Diseases.  27:279-284. 2001
2000 Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: The NIMH Alzheimer disease genetics initiativeAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics.  96:823-830. 2000
2000 Frequency of caucasian hemochromatosis-associated tyr250stop (y250x) mutation in the non-classicaf, transferred receptor gene tfr2 in african americansBlood.  96. 2000
2000 Hemochromatosis and primary antibody deficiency: Occurrence in the same individuals and frequency of HFE mutations in common variable immunodeficiency (CVID) and IgG subclass deficiency (IgGSD)Blood.  96. 2000
2000 Transferrin saturation phenotype and HFE genotype screening for hemochromatosis and primary iron overload: Predictions from a model based on national, racial, and ethnic group composition in central alabamaGenetic Testing and Molecular Biomarkers.  4:199-206. 2000
2000 Knowledge, attitudes, and behaviors of Alabama's primary care physicians regarding cancer geneticsAcademic Medicine.  75:850-852. 2000
2000 Population screening for hemochromatosis: Has the time finally come?Current Gastroenterology Reports.  2:18-26. 2000
1999 Associations of MHC genes with levels of caries-inducing organisms and caries severity in African-American womenHuman Immunology.  60:984-989. 1999
1999 Diagnosis of hemochromatosis in family members of probands: a comparison of phenotyping and HFE genotyping.Genetics in Medicine.  1:89-93. 1999
1999 Two novel missense mutations of the HFE gene (I105T and G93R) and identification of the S65C mutation in Alabama hemochromatosis probandsBlood Cells, Molecules and Diseases.  25:147-155. 1999
1997 Molecular genetic testing for adult-onset disorders: The evolving laboratory, physician, patient interfaceJournal of Clinical Laboratory Analysis.  11:23-27. 1997
1997 Genetic and clinical description of hemochromatosis probands and heterozygotes: Evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosisBlood Cells, Molecules and Diseases.  23:135-145. 1997
1996 Genetic association of 11 β-hydroxysteroid dehydrogenase type 2 flanking microsatellites with primary hypertension in African AmericansJournal of Investigative Medicine.  44. 1996
1996 Genetic association of 11β-hydroxysteroid dehydrogenase type 2 (HSD11B2) flanking microsatellites with essential hypertension in blacksHypertension.  28:478-482. 1996
1996 Hemochromatosis: Association of severity of iron overload with genetic markersBlood Cells, Molecules and Diseases.  22:195-204. 1996
1996 Increased prevalence of mitral valve prolapse in IDDM.Diabetes Care.  19:672. 1996
1995 SSCP analysis and sequencing of the human prion protein gene (PRNP) detects two different 24 bp deletions in an atypical Alzheimer's disease familyAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics.  60:12-18. 1995
1994 Variability of the pancreatic islet beta cell/liver (GLUT 2) glucose transporter gene in NIDDM patientsDiabetologia.  37:420-427. 1994
1994 Genes within the major histocompatibility complex predict NIDDM in African-American women in AlabamaDiabetes Care.  17:1491-1494. 1994
1994 Glucokinase gene in gestational diabetes mellitus: population association study and molecular scanningDiabetologia.  37:104-110. 1994
1994 HLA in ankylosing spondylitis: Is HLA-B27 the only MHC gene involved in disease pathogenesis?Seminars in Arthritis and Rheumatism.  23:295-309. 1994
1994 Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery diseaseAmerican Journal of Clinical Nutrition.  59:940-948. 1994
1993 Concordance of 21-hydroxylase gene ratio, human leukocyte antigen haplotyping and adrenal testing results in a family with late-onset adrenal hyperplasiaJournal of Reproductive Medicine: for the obstetrician and gynecologist.  38:615-620. 1993
1993 Association of HLA phenotypes with hypertension in African Americans and Caucasoid Americans with type II diabetes, a population at risk for renal diseaseTransplantation Proceedings.  25:2400-2403. 1993
1993 Comparison of HLA phenotypes among African Americans from Alabama, Maryland, and North CarolinaTransplantation Proceedings.  25:2404-2407. 1993
1991 A novel DRB1 Allele in DR2-positive American blacksHuman Immunology.  30:41-44. 1991
1991 Abnormalities of 21-hydroxylase gene ratio and adrenal steroidogenesis in hyperandrogenic women with an exaggerated 17-hydroxyprogesterone response to acute adrenal stimulationJournal of Clinical Endocrinology and Metabolism.  73:1327-1331. 1991
1991 Autoantibodies in Black Women with Class A1 or Class GB Diabetes MellitusAmerican Journal of Perinatology: neonatal and maternal-fetal medicine.  8:103-105. 1991
1991 Gestational diabetes mellitus among African‐American womenDiabetes/metabolism reviews.  7:93-104. 1991
1991 Histocompatibility Antigen Subtypes in Black Women with Class A1 or Class GB Diabetes MellitusAmerican Journal of Perinatology: neonatal and maternal-fetal medicine.  8:106-109. 1991
1991 Restriction fragment length polymorphism analysis of HLA-DR, DQ, DP and C4 alleles in Caucasians with systemic lupus erythematosusJournal of Rheumatology.  18:14-18. 1991
1991 The relationship between maternal serum zinc levels during pregnancy and birthweightEarly Human Development.  25:75-85. 1991
1991 X-linked codominant genes control all types of non-major histocompatibility complex-restricted cytotoxicityHuman Immunology.  30:208-214. 1991
1990 A positive association between maternal serum zinc concentration and birth weightAmerican Journal of Clinical Nutrition.  51:678-684. 1990
1990 Pseudogene/functional gene ratio in late-onset 21-hydroxylase-deficient adrenal hyperplasiaAmerican Journal of Obstetrics and Gynecology.  162:633-638. 1990
1990 Risk factors for gestational diabetes in black populationDiabetes Care.  13:1196-1201. 1990
1990 The effect of genetic risk information and health risk assessment on compliance with preventive behaviorsHealth Education.  21:26-33. 1990
1989 The effect of risk assessment in conjunction with health promotion education on compliance with preventive behaviors.Journal of Allied Health.  18:271-280. 1989
1989 AS and a 9.2 kb Pvu II class I HLA DNA restriction fragment.Journal of Rheumatology.  16:141-142. 1989
1989 DNA analysis of HLA–DR and DQ genes in american blacks with systemic lupus erythematosusArthritis and Rheumatism.  32:1243-1251. 1989
1989 Familial polyarteritis nodosa: a serologic and immunogenetic analysisJournal of Rheumatology.  16:181-185. 1989
1989 Genetic analysis of IDDM: The GAW5 multiplex family datasetGenetic Epidemiology.  6:15-20. 1989
1989 Molecular analysis of HLA‐D region genes in seropositive rheumatoid arthritisTissue Antigens: immune response genetics.  34:299-308. 1989
1989 Restriction fragment polymorphisms of the HLA‐DR, HLA‐DQ, and insulin gene regions in IDDM: The GAW5 dataGenetic Epidemiology.  6:21-26. 1989
1988 Molecular genetic studies of rheumatoid arthritisAmerican Journal of Medicine.  85:23-25. 1988
1988 Restriction fragment length polymorphism analysis in ankylosing spondylitisAmerican Journal of Medicine.  85:48-50. 1988
1988 Association of HLA-linked factor B with gestational diabetes mellitus in black womenAmerican Journal of Obstetrics and Gynecology.  159:805-806. 1988
1988 Re: Methotrexate in the treatment of arthritis and connective tissue diseaseCleveland Clinic Journal of Medicine.  55:279. 1988
1987 Analysis of restriction fragment length polymorphisms in rheumatic diseasesRheumatic Disease Clinics of North America.  13:353-367. 1987
1987 Scleroderma: DR antigens, autoantibodies and clinical manifestationsClinical and Experimental Rheumatology.  5:317-321. 1987
1987 Association of restriction fragment-length polymorphisms with major histocompatibility complex class II phenotypes in white and black individualsTransplantation Proceedings.  19:826-832. 1987
1987 Toxicity to methotrexate in rheumatoid arthritisJournal of Rheumatology.  14:74-79. 1987
1987 Enhanced in vitro IgM rheumatoid factor synthesis in seropositive rheumatoid arthritis familiesRheumatology International: clinical and experimental investigations.  7:71-75. 1987
1987 Risk factor surveys of the adult populations of the state of Alabama and Jefferson County.The Alabama journal of medical sciences.  24:143-149. 1987
1987 Toxicity due to remission inducing drugs in RA.Journal of Rheumatology.  14:175-176. 1987
1987 Analyses of hla linkage in white families with multiple cases of seropositive rheumatoid arthritisArthritis and Rheumatism.  30:1115-1123. 1987
1987 Association of a 9.2‐kilobase pvu ii class i major histocompatibility complex restriction fragment length polymorphism with ankylosing spondylitisArthritis and Rheumatism.  30:894-900. 1987
1987 DR beta Taq I restriction fragment length polymorphism (RFLP) associated with insulin dependent diabetes mellitus (IDDM).Disease Markers.  5:109-117. 1987
1987 Futility of predicting onset of type I diabetes mellitus.Diabetes Care.  10:788-789. 1987
1987 Lack of association between hla–dr2 and clinical response to methotrexate in patients with rheumatoid arthritisArthritis and Rheumatism.  30:218-220. 1987
1986 HLA antigens and gold toxicity in American blacks with rheumatoid arthritisRheumatology International: clinical and experimental investigations.  6:13-17. 1986
1986 DR2 positivity and response to methotrexate in rheumatoid arthritisArthritis and Rheumatism.  29:151-151. 1986
1986 Host Factors in Juvenile PeriodontitisJournal of Dental Research.  65:394-399. 1986
1986 Purification and characterization of recombinant murine immune interferonFEBS Letters.  205:200-204. 1986
1985 HLA restriction fragment length polymorphisms associated with insulin-dependent diabetes mellitus and the seronegative spondyloarthropathiesBioscience Reports: molecular and cellular biology of the cell surface.  5:815-829. 1985
1985 Immunotherapy of insulin-dependent diabetes.The Alabama journal of medical sciences.  22:311-314. 1985
1985 DR antigens in systemic sclerosis: lack of clinical correlationsTissue Antigens: immune response genetics.  26:156-158. 1985
1985 Familial studies in human brucellosisTissue Antigens: immune response genetics.  26:77-79. 1985
1985 Genetic predisposition to acute lymphocytic leukemia in American blacks. A pediatric oncology group studyCancer.  55:2880-2882. 1985
1985 HLA‐Bw35 and gold toxicity in rheumatoid arthritisArthritis and Rheumatism.  28:236-237. 1985
1984 The complement component C4 in black Americans with Type 1 (insulin-dependent) diabetes mellitusDiabetologia.  26:166-168. 1984
1984 A simple methodology for the routine production and partial purification of human lymphoblastoid interferon.Advances in Experimental Medicine and Biology.  172:269-279. 1984
1984 Association of factor B with ischemic heart disease (IHD).Progress in clinical and biological research.  147:479-480. 1984
1984 Dr Antigens and Gold Toxicity in white rheumatoid arthritis patientsArthritis and Rheumatism.  27:601-605. 1984
1984 Modification of NK cell activity by monoclonal antibodies to target cell glycoproteinsThe FASEB Journal.  43. 1984
1984 Productive murine leukemia virus (MuLV) infection of EL4 T-lymphoblastoid cells: selective elevation of H-2 surface expression and possible association of Thy-1 antigen with viruses.Advances in Experimental Medicine and Biology.  172:365-381. 1984
1984 The effects of soluble membrane glycoproteins from K562 target cells on NK activityThe FASEB Journal.  43. 1984
1983 DR antigen distribution in blacks with rheumatoid arthritisJournal of Rheumatology.  10:579-583. 1983
1983 Age at onset of insulin-dependent diabetes mellitus associated with BfF1Immunogenetics.  17:437-440. 1983
1983 CREG antigens differentially influence expression of extraarticular manifestations in whites and blacks with rheumatoid arthritisSeminars in Arthritis and Rheumatism.  13:169-173. 1983
1983 Genetic analysis of multiply-affected families of insulin-dependent diabetes mellitus (Iddm) probandsHuman Heredity: international journal of human and medical genetics.  33:344-356. 1983
1983 PHENOTYPES OF THE FOURTH COMPLEMENT COMPONENT (C4) IN BLACK AMERICANS FROM THE SOUTHEASTERN UNITED STATESInternational Journal of Immunogenetics.  10:199-204. 1983
1983 Population genetic analyses of insulin dependent diabetes mellitus using HLA allele frequenciesClinical Genetics: an international journal of genetics and molecular medicine.  23:405-414. 1983
1983 Seronegative rheumatoid arthritis and b7‐creg: disparate resultsArthritis and Rheumatism.  26:1412-1413. 1983
1982 Increase of hla-dr4 in melanoma patients fromCancer Research.  42:4276-4279. 1982
1982 Properdin factor B in black Type 1 (insulin-dependent) diabetic patientsDiabetologia.  22:483-485. 1982
1982 Associations of properdin factor B with melanomaCancer Genetics.  5:247-251. 1982
1982 Evidence for genetic admixture as a determinant in the occurrence of insulin-dependent diabetes mellitus in U.S. blacksDiabetes.  31:532-537. 1982
1982 HLA-A, -B, and -DR associations in type I diabetes mellitus with onset after age fortyDiabetes.  31:122-125. 1982
1982 Properdin factor B and acute lymphocytic leukemia (ALL)Cancer.  50:2369-2371. 1982
1982 Seronegative rheumatoid arthritis.Arthritis and Rheumatism.  25:502-507. 1982
1981 A method for dialysis of microsamplesAnalytical Biochemistry.  118:399-400. 1981
1981 A technique for the detection of variable electrophoretic patterns of hair proteinsElectrophoresis.  2:333-334. 1981
1981 Five‐year perspective of the large‐scale growth of mammalian cells in suspension cultureBiotechnology and Bioengineering.  23:2717-2735. 1981
1981 HLA Associations with Insulin‐Dependent Diabetes Mellitus in a Sample of the American Black PopulationTissue Antigens: immune response genetics.  17:286-293. 1981
1981 PROPERDIN FACTOR B POLYMORPHISM IN BLACK AMERICANSInternational Journal of Immunogenetics.  8:519-521. 1981
1980 HLA in Juvenile DiabetesNew England Journal of Medicine.  302:405-406. 1980
1980 HLA in juvenile diabetes.New England Journal of Medicine.  302:406. 1980
1980 Identification and characterization of protein antigens of two mycoplasma speciesJournal of Immunology.  124:997-999. 1980
1980 Isolation and partial characterization of the human homologue of Thy-1Journal of Experimental Medicine.  151:400-406. 1980
1979 Interaction of murine T-cell surface antigens with Mycoplasma hyorhinis.Advances in Experimental Medicine and Biology.  121 B:65-80. 1979
1979 Propagation and Scaling-Up of Suspension CulturesMethods in Enzymology.  58:211-221. 1979
1978 New vistas in the etiology, genetics, pathogenesis and natural history of juvenile onset diabetesJournal of the Medical Association of the State of Alabama.  48:25-39. 1978
1978 Association of Thy-1 differentiation alloantigen with synaptic complexes isolated from mouse brainProceedings of the National Academy of Sciences of USA.  75:3283-3287. 1978
1978 Distribution of Thy-1 differentiation alloantigen in the rat nervous system and in a cell line derived from a rat peripheral neurinomaDevelopmental Neuroscience.  1:110-117. 1978
1978 Origin of the minor glycoproteins of murine leukemia virusesJournal of Virology.  28:84-94. 1978
1978 Selective association of murine T lymphoblastoid cell surface alloantigens with Mycoplasma hyorhinisProceedings of the National Academy of Sciences of USA.  75:4479-4483. 1978
1977 Isolation and characterization of murine cell surface components: I. Purification of milligram quantities of thy-1.1*Journal of Experimental Medicine.  146:986-1000. 1977
1977 Production and chemical characterization of cell membrane glycoproteins.The Alabama journal of medical sciences.  14:166-175. 1977
1977 Production of Milligram Quantities of H-2K and Thy-1 Alloantigens by Large-Scale Mammalian Cell CultureExperimental Biology and Medicine.  155:296-300. 1977
1977 The developmental appearance of Thy-1 in mouse reaggregating brain cell culturesDevelopmental Biology.  60:331-335. 1977
1975 An evaluation of suspension culture systems for the growth of murine lymphoblastoid lines expressing TL and Thy‐1 alloantigensBiotechnology and Bioengineering.  17:629-657. 1975
1975 Design of a large‐scale mammalian cell, suspension culture facilityBiotechnology and Bioengineering.  17:659-673. 1975
1975 Growth properties and alloantigenic expression of murine lymphoblastoid cell linesJournal of Experimental Medicine.  142:378-390. 1975
1975 Purification of plasma membranes from murine lymphoblastic cell lines expressing Thy 1 and Tl alloantigensThe FASEB Journal.  34. 1975
1974 Estimation of the amount and tissue distribution of rat Thy‐1.1 antigenEuropean Journal of Immunology.  4:598-602. 1974
1973 Characterization of a teleost immunoglobulin: The immune macroglobulin from the channel catfish, Ictalurus punctatusComparative Biochemistry and Physiology - B: Comparative Biochemistry.  46. 1973
1973 Variations among sublines of inbred AKR miceNature.  245:8-10. 1973
1973 The carbohydrate composition of invertebrate hemagglutinin subunits isolated from the lobster Panulirus argus and the oyster Crassostrea virginicaComparative Biochemistry and Physiology - B: Comparative Biochemistry.  44:185-189. 1973
1972 The carbohydrate composition of immunoglobulins from diverse species of vertebrates.Journal of Immunology.  109:371-381. 1972
1972 Purification and Characterization of Two Classes of Immunoglobulins from the Marine Toad, Bufo marinusBiochemistry.  11:2751-2759. 1972
1972 Phylogeny of immunoglobulins-purification and physico-chemical characterization of the immune macroglobulin from the turtle, Pseudemus seriptaImmunochemistry.  9. 1972
1971 Isolation and characterization of the immune macroglobulin from the paddlefish, Polyodon spathula.Journal of Biological Chemistry.  246:6760-6769. 1971
1971 Species distribution of J chain.Journal of Immunology.  107:1211-1212. 1971
1971 Isolation and physico-chemical characterization of the "IgM-like" immunologlobulin from the stingray Dasyatis americana.Journal of Immunology.  107:782-793. 1971
1971 The carbohydrate composition of immunoglobulins GBBA: General Subjects.  237:442-449. 1971
1971 Humoral antibody responses in the gar, Lepisosteus osseus.Immunology.  20:1009-1017. 1971
1971 Phylogeny of Immunoglobulins. Characterization of a 14S Immunoglobuim from the Gar, Lepisosteus osseusBiochemistry.  10:2028-2036. 1971
1971 Humoral immune factors in the paddlefish, Polyodon spathulaComparative Biochemistry and Physiology - B: Comparative Biochemistry.  38:523-527. 1971
1971 Comparative immunology: The hemolytic complement system of the anuran amphibian, Bufo marinusComparative Biochemistry and Physiology - A: Comparative Physiology.  38:483-488. 1971
1971 Bactericidal antibody response in the Pacific hagfish, Eptatretus stoutii.Infection and Immunity.  4:160-166. 1971
1971 Tetrameric immune macroglobulins in three orders of bony fishes.Proceedings of the National Academy of Sciences of USA.  68:107-111. 1971
1970 Biological sciences: N-Terminal sequences of immunoglobulin heavy and light chains from three species of lower vertebratesNature.  228:991-992. 1970
1970 Reactions of sipunculid coelomic fluid with erythrocytesLife Sciences.  9:145-152. 1970
1969 Induced bactericidal response in a sipunculid wormNature.  222:695. 1969
1969 Physical and chemical characterization of an oyster hemagglutinin.Journal of Biological Chemistry.  244:4128-4135. 1969
1969 A bactericidal system in the lobster Homarus americanusJournal of Invertebrate Pathology.  13:463-464. 1969
1969 Attempt to induce a bactericidal response in the oyster.Journal of Bacteriology.  97:462-463. 1969
1969 Comparative Immunology: Natural Hemolytic System of the Spiny Lobster, Panulirus argusExperimental Biology and Medicine.  130:322-326. 1969
1969 Immunological capabilities of the oyster Crassostrea virginicaComparative Biochemistry and Physiology.  29:149-160. 1969
1969 Induced Bactericidal Response in the California Spiny Lobster Panulirus interruptusExperimental Biology and Medicine.  132:111-114. 1969
1969 Induced bactericidal response in the hagfish.Journal of Bacteriology.  99:626-628. 1969
1969 Lack of a bactericidal response in the earthworm Lumbricus terrestris after immunization with bacterial antigensJournal of Invertebrate Pathology.  14:402-406. 1969
1969 Secondary and tertiary responses of the induced bactericidin from the West Indian spiny lobster, Panulirus argus.Journal of Bacteriology.  98:943-946. 1969
1969 Specificity of the induced bactericidin of the West Indian spiny lobster, Panulirus argus.Journal of Bacteriology.  98:947-948. 1969
1968 T2 Bacteriophage Clearance in the Lemon SharkExperimental Biology and Medicine.  128:977-979. 1968
1968 An Induced Bactericidin in the Spiny Lobster, Panulirus argusExperimental Biology and Medicine.  128:394-398. 1968
1968 Bacteriophage clearance in the oyster (Crassotrea virginica).Journal of Bacteriology.  95:1260-1266. 1968
1967 Comparative immunological studies with the oyster, Crassostrea virginicaIn vitro.  3:139-145. 1967
1967 Complement-dependent systems and the phylogeny of immunityIn vitro.  3:146-153. 1967

Chapter

Year Title Altmetric
2019 Hepcidin, iron, and bacterial infection.  223-242. 2019

Education And Training

  • Doctor of Philosophy in Immunology, University of Alabama at Birmingham 1970
  • Full Name

  • Ronald Acton